The Hamner Institutes Announce Partnership With China Medical City
Agreement Creates New Bridge Between North Carolina And China
[USPRwire, Sun May 24 2009] The Hamner Institutes for Health Sciences has signed an agreement with China Medical City to create the Hamner-China Medical City Institute for International Drug Development. Building on strengths of the two organizations in translational research, business development, and education, the Institute will help to produce new biomedical technologies that benefit the United States and People’s Republic of China as well as the rest of the world.
During the first phase of this agreement, the Institute for International Drug Development will be established at The Hamner’s campus in Research Triangle Park (RTP), North Carolina, and will focus on preclinical drug development and compliance with FDA regulatory standards. After the partners validate research capabilities and new technologies at The Hamner campus, they will transfer them to China Medical City, a new life science park located in the Yangtze River Delta north of Shanghai.
In 2008, The Hamner launched a Bioscience Accelerator on its 56-acre campus in the heart of RTP. There are two initial start-ups: BioMedomics, a diagnostics company started by Chinese-American scientists, and b3bio, a spinout from Duke University.
Newsummit Biopharma, one of China Medical City’s premier partners, is establishing its North American business center in The Hamner’s Bioscience Accelerator. Newsummit Biopharma is a contract research and technology development company whose service platform includes support for commercialization, intellectual property, funding, and staffing in science and technology parks throughout China.
The partnership with China Medical City and Newsummit Biopharma creates a vital bridge of opportunity between North Carolina and China. Acknowledged worldwide as a major hub of biotechnology, North Carolina is an ideal location for companies from China that seek to enter the U.S. market. After establishing an initial presence in RTP, which already has a strong Chinese community of scientists and business professionals, companies from China can expand around the state of North Carolina as their businesses prosper and grow.
As part of its new strategic agreement with China Medical City, The Hamner has worked with the North Carolina Department of Commerce and North Carolina Biotechnology Center, a world leader in bioscience development, to create a “North Carolina-China partner network” that supports Chinese business and educational initiatives. Other members of this innovative network include the North Carolina China Center, the North Carolina China Business Association, Council for Entrepreneurial Development, and North Carolina Research Parks Network as well as economic development organizations in counties such as Wake and Durham.
China Medical City and Newsummit Biopharma are actively using their network to assist North Carolina’s R&D companies, contract organizations (research, manufacturing, and commercial), and academic institutions that want to establish strategic alliances, research sites, branch offices, etc. in China. The new Hamner Bioscience Center in China Medical City and the North Carolina Department of Commerce office in Shanghai are serving as gateways for North Carolina organizations, such as Cirrus, Specialty Operations Solutions, Inc., and SyneCor, that are developing new markets in China.
“Our partnership with China Medical City has moved rapidly,” said Dr. William Greenlee, President and CEO of The Hamner Institutes for Health Sciences. “During our meeting at last year’s BIO conference in San Diego, it became clear that both organizations want to expeditiously create new strategies for capturing scientific innovations and translating them into benefits for both patients and investors. We are grateful that Newsummit Biopharma has invested in The Hamner to assist in creating the new Institute for International Drug Development.”
“In building China’s largest science park for biotechnology, pharmaceuticals, and medical technology,” said He Rong, President of China Medical City, “we have chosen only a select number of global partners initially to collaborate with us. We are pleased that The Hamner in Research Triangle Park is one of them and has joined with us to create a dynamic gateway to North Carolina and the United States as we further develop China’s biomedical industry.”
About the Hamner Institutes for Health Sciences
The Hamner Institutes for Health Sciences is a nonprofit research organization strategically located in Research Triangle Park, North Carolina. The Hamner has a strong heritage in scientific scholarship and translational research. For 35 years, scientists at The Hamner have conducted small-molecule chemical safety studies to protect the environment. The Hamner has recently expanded its mission to include drug safety, NIH-funded human disease research, and support for life science start-ups. As a neutral, independent research institute, The Hamner works collaboratively with academia, government regulatory agencies, and commercial companies to accelerate the development of new bioscience technologies.
During the past year, The Hamner has played an active role in linking together translational research programs in the RTP-Winston Salem corridor of North Carolina. For example, The Hamner and the University of North Carolina-Chapel Hill jointly created an integrated Center for Drug Safety Sciences, which is already being recognized as a leader in studying the safety of biotechnology and pharmaceutical products. Additional research and business development agreements have been established with Duke University, North Carolina State University, and Wake Forest University. For more information, please see www.thehamner.org or call (919) 558-1200.
About China Medical City
China Medical City is a high-density park of approximately 20 square kilometers that is entirely dedicated to biotech, pharmaceutical, and medical innovation. The park is being developed outside Taizhou, Jiangsu Province, which has a metropolitan population of six million people and is the hometown of Hu Jintao, the current president of China. There are five major high-technology zones in China Medical City: research and development, manufacturing and product scale up, business development, healthcare delivery (including a 600-bed research hospital), and comprehensive services for drug development. When completed, China Medical City will be the largest biomedical industrial park in China. To see video highlights of China Medical City, please visit www.youtube.com/watch?v=4kW9TTulYzE
The Hamner Institutes Media contact:
MMI Associates, Inc.
(919) 233-0300 (fax)